powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
AAP: Few Doctors Provide Firearm Injury Prevention Info in ERDoctors Eye the Danger From 'Nerf' GunsParents Say Schools Don't Help Kids With Mental Health, Chronic DiseaseIt's a Food Allergy! Where's the School Nurse?Big Rise in Hospitalized Kids With Opioid Side EffectsAAP: Opioid Dependence/Abuse Public Health Issue for ChildrenGolf Carts' Use Is Spreading, and So Is Danger to KidsState Laws Have Big Impact on Kids' Gun InjuriesHealth Tip: On Kids and PetsHurricanes May Have Longer-Lasting Impact on KidsHeath Tip: Getting Rid of Head LiceState Laws Curb Kids' Injuries Tied to Off-Road VehiclesBrown-Bagging It? Think Outside the BoxVaccine Campaign in Poor Countries to Save 20 Million LivesFor City Kids With Asthma, Nearby Green Space Is KeyHealth Tip: Fuel Your Child With a Good BreakfastIncrease in Medical Exemptions From Immunization in CaliforniaPut Flu Shot on the Back-to-School ChecklistThroat Bacteria Linked to Bone and Joint Infection in KidsHarvey's Wrath Still Poses Risks to ChildrenHeath Tip: It's Back-to-School TimeHelping Kids Adapt to a New SchoolWhite Kids More Likely to Get Unneeded AntibioticsBack to School, Back to Planning for Kids With Autism, ADHDTake the Back Pain Out of BackpacksChild Flu Vaccination Down When Nasal Spray UnavailableNasal Flu Vaccine's Demise May Mean Fewer Immunized KidsHealth Tip: Identify BullyingHealth Tip: Prepare for Your Child's Dental ProcedureIntracranial Pressure Monitoring No Benefit in Pediatric TBIFDA Approves 1st Treatment for 'Kissing Bug' Illness in ChildrenMany Parents Don't Tell Doctor About 'Complementary' Therapy Use in KidsHealth Tip: Back to School for Kids with AsthmaVaccination 101: Make Sure Kids Are Up to DateSerious Reactions to Vaccines Rarely Recur: ReviewParents Worried About Cyberbullies as School Starts UpCookies, Apples or Yogurt? Not Always a Simple Choice for KidsHaving Same-Sex Parents Won't Affect Kids' Gender Identity: StudyKids' Cases of High Blood Pressure May Rise Under New GuidelinesBack-to-School Tips … for ParentsCoping Support Assists Parents of Hospitalized ChildrenA Violent Environment Can Wreck Kids' GradesDo Pets Really Boost Kids' Health?Rotavirus Vaccine Cut Kids' Hospitalization, Medical CostsHealth Tip: Childhood Obesity Can Trigger Adult ProblemsDecline in Kids' Ear Infections Linked to Pneumococcal VaccinePicky Eater? It Might Just Be Your Child's PersonalityPrenatal Exposure to Certain Flame Retardants Linked to Lower IQsHealth Tip: Protect Your Kids From LeadKnow the Signs of Concussion
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)
Child Development & Parenting: Middle (8-11)
Child Development Theory: Adolescence (12-24)

FDA Approves 1st Treatment for 'Kissing Bug' Illness in Children

HealthDay News
by -- Margaret Farley Steele
Updated: Aug 30th 2017

new article illustration

WEDNESDAY, Aug. 30, 2017 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first drug to treat Chagas infection -- "kissing bug" disease -- in the United States.

Under its accelerated approval process, the agency on Tuesday OK'd use of benznidazole for children aged 2 to 12 who have Chagas disease. The infection is caused by a parasite called Trypanosoma cruzi, which is transmitted by infected triatomine bugs.

The insects feed on the blood of humans (and animals) at night. Because it often bites near the eye or mouth, it's been dubbed the "kissing bug."

According to the U.S. Centers for Disease Control and Prevention, the bug defecates while feeding, generally when someone is sleeping. The infection is spread if the feces is rubbed into the bite or mucous membranes.

Chagas disease is also transmitted through blood transfusions, or from a mother to her child during pregnancy, the FDA said.

Without early treatment, the disease can eventually cause serious heart illness, and interfere with swallowing and digestion.

Although residents of rural Latin American regions are most likely to get Chagas disease, the "kissing bugs" have been identified in the southern half of the United States. And the CDC estimates 300,000 people in the United States have Chagas disease.

"The FDA is committed to making available safe and effective therapeutic options to treat tropical diseases," Dr. Edward Cox, director of the FDA's Office of Antimicrobial Products, said in an agency news release.

Benznidazole is made by Chemo Research, S. L., of Madrid, Spain. It was approved after two clinical trials in kids aged 6 to 12. In one trial, about six out of 10 children treated with benznidazole had an antibody test change from positive to negative versus just 14 percent of kids who received a placebo, the FDA reported.

Similar results were seen in the second trial, the FDA said.

Side effects from benznidazole were generally mild, including stomach pain, rash, weight loss, headache, nausea and vomiting, abnormal white blood cell count and appetite loss. But more severe risks were reported, too, including serious skin reactions, nervous system effects and bone marrow depression.

Also, the FDA said animal studies have suggested benznidazole could cause fetal harm when administered in pregnancy.

The FDA explained it speeds up drug approval when "there is unmet medical need and adequate and well-controlled trials." However, "further study is required to verify and describe the anticipated clinical benefit of benznidazole," it said.

More information

To learn more about Chagas disease, see the U.S. Centers for Disease Control and PreveNtion.